药房福利管理人员:历史,商业实践,经济学和政策
T Joseph Mattingly1, David A Hyman2, Ge Bai3
1Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City.
JAMA health forum
|November 3, 2023
概括
药房福利管理人员 (PBM) 是药品分销的关键中介机构. 政策应该促进PBM竞争,使消费者受益,而不仅仅是其他行业参与者.
科学领域:
- 卫生经济学 卫生经济学
- 制药政策 制药政策
- 产业分析 产业分析
背景情况:
- 药房福利管理人员 (PBM) 是制药供应链中的中心中间人.
- 它们日益增长的作用导致了大量的政策审查.
- 缺乏对PBM历史,实践和政策的系统描述.
研究的目的:
- 为提供PBM行业的全面概述.
- 分析当前的政策格局及其对PBM和患者护理的潜在影响.
主要方法:
- 审查历史数据,行业实践和出版物.
- 分析学术文献,法规,法规,法庭案件和立法改革.
主要成果:
- 随着水平/垂直整合和市场集中,PBMs已经发展起来.
- 关键功能包括表单设计,利用管理,价格谈判,网络形成和邮购服务.
- 批评侧重于缺乏竞争,定价,代理问题和透明度.
结论:
- 在制药管理和分销中,PBMs至关重要.
- 监管应该优先加强PBM竞争,以解决市场故障.
- 政策必须满足消费者的需求,而不是其他市场参与者的狭利益.
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
2.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.1K
Drug Control Governance: Regulatory Bodies and Their Impact
163
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
163
Pharmacodynamics: Overview and Principles
1.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.2K
Pharmacovigilance
860
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
860
Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Pharmacokinetic Models: Overview
720
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
720


